Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults

Manuscript Number: 

14-8009R2

Author(s): 
Christopher M. Callahan, Martin R. Farlow, Tatiana M. Foroud, Sujuan Gao, Hugh C. Hendrie, Emrin Horgusluoglu, Mark H. Inlow, Sungeun Kim, Brenna C. McDonald, Kwangsik Nho, Alexander B. Niculescu, Vijay K. Ramanan, Shannon L. Risacher, Andrew J. Saykin

Disclosures

Christopher M. Callahan

  • Nothing to Disclose

Martin R. Farlow

  • Nothing to Disclose

Tatiana M. Foroud

  • Nothing to Disclose
    Consulting Fees:
    Advisory boards for non-profit or governmental advisory boards only

Sujuan Gao

  • Equity:
    Ford, Intel, Microsoft, Pfizer, Republic Service, Wells Fargo, Applied Materials, Twitter, BP: 100 shares each. GE, 250 shares; Coke, 200; Exxon, Procter Gamble: 50. Abbot: 120 shares

Hugh C. Hendrie

  • Nothing to Disclose

Emrin Horgusluoglu

  • Nothing to Disclose

Mark H. Inlow

  • Nothing to Disclose

Sungeun Kim

  • Nothing to Disclose

Brenna C. McDonald

  • Grants
    • Agency: 
      Ninesigma, Inc.
      Dates: 
      5/1/14-4/30/15

Kwangsik Nho

  • Nothing to Disclose

Alexander B. Niculescu

  • Nothing to Disclose

Vijay K. Ramanan

  • Nothing to Disclose

Shannon L. Risacher

  • Nothing to Disclose

Andrew J. Saykin

  • Consulting Fees:
    Eli Lilly, Siemens Healthcare, Arkley BioTek (consultant) - no relationship to findings reported in this manuscript; Springer (Editor-in-chief, Brain Imaging and Behavior)
    Lecture Fees:
    Eli Lilly, Siemens Healthcare (honoraria for speaking at non-commercial scientific symposia)